How do you pay?

How to pay the least

Ask for the cash price

HAEGARDA C1 Esterase Inhibitor Subcutaneous

This medicine is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for HAEGARDA C1 Esterase Inhibitor Subcutaneous’s cash price, and one or two other pharmacies too.

Compare every option

Question
Brand nameHAEGARDA C1 Esterase Inhibitor Subcutaneous
Authorized generichuman c1-esterase inhibitor
Regular generichuman c1-esterase inhibitor
What you’d pay
Cash priceFree trialFrom the maker
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as the brand?
The original
–
–

Brand nameThe maker’s free trial

HAEGARDA QuickStart Program

Free trial from CSL Behring

HAEGARDA C1 Esterase Inhibitor Subcutaneous’s maker offers new patients a free trial. See its page for how to get it.

Sign up on haegarda.com 

Or call 1-844-423-4273.

From the maker’s site, checked November 2, 2026. Check the maker’s page for who can use it.

Authorized genericNot sold

There isn’t one. An authorized generic is HAEGARDA C1 Esterase Inhibitor Subcutaneous itself, from the same company, sold without the brand name, and usually for less. For now HAEGARDA C1 Esterase Inhibitor Subcutaneous is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

This medicine is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

HAEGARDA is a plasma-derived concentrate of C1 Esterase Inhibitor (Human) (C1-INH) indicated for routine prophylaxis to prevent Hereditary Angioedema (HAE) attacks in patients 6 years of age and older.

Source: the FDA label for HAEGARDA C1 Esterase Inhibitor Subcutaneous (CSL Behring GmbH), February 4, 2022. Full label on DailyMed 

Good to know